Helicobacter Antibodies

Santa Cruz Biotechnology offers a broad range of Helicobacter Antibodies for the detection and analysis of Helicobacter species, particularly Helicobacter pylori. Helicobacter Antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Helicobacter pylori is a gram-negative bacterium that colonizes the gastric epithelium and is a major contributor to gastric diseases, including peptic ulcers and gastric cancer. Understanding the role of Helicobacter pylori in gastric conditions is crucial for developing effective treatments and preventive strategies. The study of Helicobacter species continues to reveal important insights about gastrointestinal health and disease. Research focusing on Helicobacter pylori has significantly advanced our understanding of bacterial pathogenesis and host-pathogen interactions. Investigating the molecular mechanisms of Helicobacter pylori infection has opened new avenues for therapeutic interventions. Current research directions include studying virulence factors, antibiotic resistance mechanisms, and host immune responses. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of Helicobacter-related diseases and potential therapeutic approaches.